{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:11:54Z","timestamp":1780582314393,"version":"3.54.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005366","name":"Universitetet i Oslo","doi-asserted-by":"publisher","award":["NS9013S"],"award-info":[{"award-number":["NS9013S"]}],"id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","award":["2020063"],"award-info":[{"award-number":["2020063"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008730","name":"The Norwegian Cancer Society","doi-asserted-by":"publisher","award":["270870"],"award-info":[{"award-number":["270870"]}],"id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.neo.2026.101272","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T04:16:16Z","timestamp":1768277776000},"page":"101272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Cell type composition in bulk prostate cancer tissue is a prognostic biomarker"],"prefix":"10.1016","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4684-317X","authenticated-orcid":false,"given":"Xiaokang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1749-7423","authenticated-orcid":false,"given":"Bjarne","family":"Johannessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1789-7523","authenticated-orcid":false,"given":"Susanne G.","family":"Kidd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Bogaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ane","family":"Stranger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrika","family":"Axcrona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Axcrona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5609-4048","authenticated-orcid":false,"given":"Rolf I.","family":"Skotheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2026.101272_bib0001","article-title":"Global cancer observatory: cancer today","author":"Ferlay","year":"2020","journal-title":"Int. Agency Res. Cancer"},{"issue":"9","key":"10.1016\/j.neo.2026.101272_bib0002","first-page":"499","article-title":"The movember prostate cancer landscape analysis: an assessment of unmet research needs","volume":"17","author":"Kouspou","year":"2020","journal-title":"Nat. Rev. Urol. 2020 179"},{"issue":"6","key":"10.1016\/j.neo.2026.101272_bib0003","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.humpath.2010.02.011","article-title":"Multifocal prostate cancer: biologic, prognostic, and therapeutic implications","volume":"41","author":"Andreoiu","year":"2010","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.neo.2026.101272_bib0004","doi-asserted-by":"crossref","DOI":"10.1038\/s41417-022-00444-7","article-title":"Expressed prognostic biomarkers for primary prostate cancer independent of multifocality and transcriptome heterogeneity","author":"Str\u00f8mme","year":"2022","journal-title":"Cancer Gene Ther."},{"issue":"6","key":"10.1016\/j.neo.2026.101272_bib0005","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.neo.2021.05.012","article-title":"High expression of SCHLAP1 in primary prostate cancer is an independent predictor of biochemical recurrence, despite substantial heterogeneity","volume":"23","author":"Kidd","year":"2021","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.neo.2026.101272_bib0006","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41598-019-49964-7","article-title":"Interfocal heterogeneity challenges the clinical usefulness of molecular classification of primary prostate cancer","volume":"9","author":"Carm","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.neo.2026.101272_bib0007","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.eururo.2018.08.009","article-title":"Multifocal primary prostate cancer exhibits high degree of genomic heterogeneity","volume":"75","author":"L\u00f8vf","year":"2019","journal-title":"Eur. Urol."},{"issue":"3","key":"10.1016\/j.neo.2026.101272_bib0008","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.euf.2018.01.006","article-title":"Genomic heterogeneity within individual prostate cancer foci impacts predictive biomarkers of targeted therapy","volume":"5","author":"VanderWeele","year":"2019","journal-title":"Eur. Urol. Focus."},{"issue":"2","key":"10.1016\/j.neo.2026.101272_bib0009","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.eururo.2016.07.008","article-title":"Intratumoral and intertumoral genomic heterogeneity of multifocal localized prostate cancer impacts molecular classifications and genomic prognosticators","volume":"71","author":"Wei","year":"2017","journal-title":"Eur. Urol."},{"issue":"2","key":"10.1016\/j.neo.2026.101272_bib0010","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.eururo.2012.03.050","article-title":"Exome sequencing of prostate cancer supports the hypothesis of independent tumour origins","volume":"63","author":"Lindberg","year":"2013","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.neo.2026.101272_bib0011","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1590\/s1677-5538.ibju.2016.0656","article-title":"Biochemical recurrence after radical prostatectomy: what does it mean?","volume":"44","author":"Tourinho-Barbosa","year":"2018","journal-title":"Int. Braz. J. Urol."},{"key":"10.1016\/j.neo.2026.101272_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.595657","article-title":"Immune-related gene-based novel subtypes to establish a model predicting the risk of prostate cancer","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.neo.2026.101272_bib0013","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12894-019-0479-z","article-title":"Where is the limit of prostate cancer biomarker research? Systematic investigation of potential prognostic and diagnostic biomarkers","volume":"19","author":"Kremer","year":"2019","journal-title":"BMC. Urol."},{"issue":"3","key":"10.1016\/j.neo.2026.101272_bib0014","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.eururo.2014.05.004","article-title":"A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling","volume":"66","author":"Klein","year":"2014","journal-title":"Eur. Urol."},{"issue":"6","key":"10.1016\/j.neo.2026.101272_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066855","article-title":"Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy","volume":"8","author":"Erho","year":"2013","journal-title":"PLoS. One"},{"issue":"3","key":"10.1016\/j.neo.2026.101272_bib0016","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1470-2045(10)70295-3","article-title":"Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study","volume":"12","author":"Cuzick","year":"2011","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.neo.2026.101272_bib0017","first-page":"1","article-title":"Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity","volume":"9","author":"Berglund","year":"2018","journal-title":"Nat. Commun. 2018 91"},{"issue":"1","key":"10.1016\/j.neo.2026.101272_bib0018","first-page":"1","article-title":"Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling","volume":"12","author":"Brady","year":"2021","journal-title":"Nat. Commun. 2021 121"},{"issue":"1","key":"10.1016\/j.neo.2026.101272_bib0019","first-page":"1","article-title":"Single cell and spatial transcriptomics highlight the interaction of club-like cells with immunosuppressive myeloid cells in prostate cancer","volume":"15","author":"Kiviaho","year":"2024","journal-title":"Nat. Commun. 2024 151"},{"key":"10.1016\/j.neo.2026.101272_bib0020","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network, The molecular taxonomy of primary prostate cancer, Cell 163 (4) (Nov. 2015) 1011\u20131025, doi:10.1016\/j.cell.2015.10.025.","DOI":"10.1016\/j.cell.2015.10.025"},{"issue":"6","key":"10.1016\/j.neo.2026.101272_bib0021","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.ccell.2018.10.016","article-title":"Molecular evolution of early-onset prostate cancer identifies Molecular risk markers and clinical trajectories","volume":"34","author":"Gerhauser","year":"2018","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.neo.2026.101272_bib0022","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1158\/0008-5472.CAN-13-2699","article-title":"Global transcriptome analysis of formalin-fixed prostate cancer specimens identifies biomarkers of disease recurrence","volume":"74","author":"Long","year":"2014","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.neo.2026.101272_bib0023","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.neo.2026.101272_bib0024","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.tcb.2014.11.006","article-title":"Microenvironmental regulation of therapeutic response in cancer","volume":"25","author":"Klemm","year":"2015","journal-title":"Trends. Cell Biol."},{"issue":"2","key":"10.1016\/j.neo.2026.101272_bib0025","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3892\/ol.2021.13171","article-title":"Role of the tumor immune microenvironment in tumor immunotherapy","volume":"23","author":"Zhou","year":"2022","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.neo.2026.101272_bib0026","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.annonc.2020.11.020","article-title":"Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancer","volume":"32","author":"Perets","year":"2021","journal-title":"Ann. Oncol."},{"issue":"571","key":"10.1016\/j.neo.2026.101272_bib0027","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz6667","article-title":"Combination of metabolic intervention and T cell therapy enhances solid tumor immunotherapy","volume":"12","author":"Hao","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.neo.2026.101272_bib0028","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1186\/s12885-018-4829-0","article-title":"Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma","volume":"18","author":"Keung","year":"2018","journal-title":"BMC. Cancer"},{"key":"10.1016\/j.neo.2026.101272_bib0029","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.21037\/atm.2019.06.12","article-title":"New insights in predictive determinants of the tumor immune microenvironment for immune checkpoint inhibition: a never ending story?","volume":"7","author":"Eckstein","year":"2019","journal-title":"Ann. Transl. Med."},{"issue":"4","key":"10.1016\/j.neo.2026.101272_bib0030","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity."},{"issue":"8","key":"10.1016\/j.neo.2026.101272_bib0031","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1158\/0008-5472.CAN-19-2948","article-title":"Revisiting immunotherapy: a focus on prostate cancer","volume":"80","author":"Cha","year":"2020","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.neo.2026.101272_bib0032","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1672494","article-title":"Tumor-infiltrating lymphocytes from human prostate tumors reveal anti-tumor reactivity and potential for adoptive cell therapy","volume":"8","author":"Yunger","year":"2019","journal-title":"Oncoimmunology."},{"issue":"1","key":"10.1016\/j.neo.2026.101272_bib0033","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s40425-018-0367-1","article-title":"Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from the Cancer Genome Atlas (TCGA)","volume":"6","author":"Danaher","year":"2018","journal-title":"J. ImmunOther Cancer"},{"issue":"22","key":"10.1016\/j.neo.2026.101272_bib0034","doi-asserted-by":"crossref","first-page":"6764","DOI":"10.1158\/1078-0432.CCR-17-0019","article-title":"Immunotherapy of prostate cancer: facts and hopes","volume":"23","author":"Bilusic","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2026.101272_bib0035","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3389\/fimmu.2019.00603","article-title":"The tumor immune contexture of prostate cancer","volume":"10","author":"Vitkin","year":"2019","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.neo.2026.101272_bib0036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006701","article-title":"New functionalities in the TCGAbiolinks package for the study and integration of cancer data from GDC and GTEx","volume":"15","author":"Mounir","year":"2019","journal-title":"PLoS. Comput. Biol."},{"key":"10.1016\/j.neo.2026.101272_bib0037","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.12688\/f1000research.8923.1","article-title":"TCGA workflow: analyze cancer genomics and epigenomics data using bioconductor packages","volume":"5","author":"Silva","year":"2016","journal-title":"F1000Res."},{"issue":"8","key":"10.1016\/j.neo.2026.101272_bib0038","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","article-title":"TCGAbiolinks: an R\/bioconductor package for integrative analysis of TCGA data","volume":"44","author":"Colaprico","year":"2016","journal-title":"Nucleic. Acids. Res."},{"issue":"9","key":"10.1016\/j.neo.2026.101272_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106397","article-title":"RTCGAToolbox: a new tool for exporting TCGA firehose data","volume":"9","author":"Samur","year":"2014","journal-title":"PLoS. One"},{"issue":"269","key":"10.1016\/j.neo.2026.101272_bib0040","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"issue":"15","key":"10.1016\/j.neo.2026.101272_bib0042","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1093\/bioinformatics\/btt293","article-title":"PurBayes: estimating tumor cellularity and subclonality in next-generation sequencing data","volume":"29","author":"Larson","year":"2013","journal-title":"Bioinformatics."},{"key":"10.1016\/j.neo.2026.101272_bib0043","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.26476","article-title":"Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data","volume":"6","author":"Racle","year":"2017","journal-title":"Elife"},{"issue":"12","key":"10.1016\/j.neo.2026.101272_bib0044","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics."},{"key":"10.1016\/j.neo.2026.101272_bib0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1023\/A:1023949509487","article-title":"Consensus clustering: a resampling-based method for class discovery and visualization of gene expression microarray data","volume":"52","author":"Monti","year":"2003","journal-title":"Mach. Learn."},{"issue":"7","key":"10.1016\/j.neo.2026.101272_bib0046","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic. Acids. Res."},{"issue":"5","key":"10.1016\/j.neo.2026.101272_bib0047","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS J. Integr. Biol."},{"key":"10.1016\/j.neo.2026.101272_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104552","article-title":"Machine learning approaches for prediction of bipolar disorder based on biological, clinical and neuropsychological markers: a systematic review and meta-analysis","author":"Colombo","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.neo.2026.101272_bib0049","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12020224","article-title":"Transdiagnostic symptom subtypes to predict response to therapeutic transcranial magnetic stimulation in major depressive disorder and posttraumatic stress disorder","volume":"12","author":"Cosmo","year":"2022","journal-title":"J. Pers. Med."},{"issue":"1","key":"10.1016\/j.neo.2026.101272_bib0050","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12935-021-02033-4","article-title":"Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions","volume":"21","author":"Zheng","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.neo.2026.101272_bib0051","article-title":"Immunological classification of pancreatic carcinomas to identify immune index and provide a strategy for patient stratification","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neo.2026.101272_bib0052","first-page":"2912","article-title":"Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling","volume":"8","author":"Tuxhorn","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2026.101272_bib0053","first-page":"4792","article-title":"Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer","volume":"9","author":"Ayala","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"14","key":"10.1016\/j.neo.2026.101272_bib0054","doi-asserted-by":"crossref","first-page":"i436","DOI":"10.1093\/bioinformatics\/btz363","article-title":"Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology","volume":"35","author":"Sturm","year":"2019","journal-title":"Bioinformatics."},{"issue":"1","key":"10.1016\/j.neo.2026.101272_bib0055","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-019-0638-6","article-title":"Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data","volume":"11","author":"Finotello","year":"2019","journal-title":"Genome Med."},{"key":"10.1016\/j.neo.2026.101272_bib0056","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","article-title":"Profiling tumor infiltrating immune cells with CIBERSORT","volume":"1711","author":"Chen","year":"2018","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.neo.2026.101272_bib0057","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: digitally portraying the tissue cellular heterogeneity landscape","volume":"18","author":"Aran","year":"2017","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.neo.2026.101272_bib0058","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","article-title":"Comprehensive analyses of tumor immunity: implications for cancer immunotherapy","volume":"17","author":"Li","year":"2016","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.neo.2026.101272_bib0059","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression","volume":"17","author":"Becht","year":"2016","journal-title":"Genome Biol."},{"issue":"5","key":"10.1016\/j.neo.2026.101272_bib0060","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"issue":"2","key":"10.1016\/j.neo.2026.101272_bib0061","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8+ T cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.neo.2026.101272_bib0062","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","article-title":"The immune contexture in cancer prognosis and treatment","volume":"14","author":"Fridman","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.neo.2026.101272_bib0063","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3389\/fimmu.2019.00622","article-title":"Double positive CD4+CD8+ T cells are enriched in urological cancers and favor T helper-2 polarization","volume":"10","author":"Bohner","year":"2019","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.neo.2026.101272_bib0064","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1007\/s00345-023-04569-8","article-title":"Prognostic value of pretreatment inflammatory markers in localised prostate cancer before radical prostatectomy","volume":"41","author":"Grogg","year":"2023","journal-title":"World J. Urol."},{"issue":"1","key":"10.1016\/j.neo.2026.101272_bib0065","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13058-016-0740-2","article-title":"Tumor-associated stromal cells as key contributors to the tumor microenvironment","volume":"18","author":"Bussard","year":"2016","journal-title":"Breast. Cancer Res."},{"issue":"3","key":"10.1016\/j.neo.2026.101272_bib0066","doi-asserted-by":"crossref","first-page":"C216","DOI":"10.1152\/ajpcell.00328.2012","article-title":"Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis","volume":"304","author":"Zeisberg","year":"2013","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.neo.2026.101272_bib0067","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-3-030-37184-5_6","article-title":"Endothelial cells in the tumor microenvironment","volume":"1234","author":"Sobierajska","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.neo.2026.101272_bib0068","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/CCO.0000000000000420","article-title":"Paracrine interactions of cancer-associated fibroblasts, macrophages and endothelial cells: tumor allies and foes","volume":"30","author":"Ronca","year":"2018","journal-title":"Curr. Opin. Oncol."},{"issue":"6","key":"10.1016\/j.neo.2026.101272_bib0069","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/pros.22957","article-title":"The prognostic value of reactive stroma on prostate needle biopsy: a population-based study","volume":"75","author":"Saeter","year":"2015","journal-title":"Prostate"},{"issue":"7989","key":"10.1016\/j.neo.2026.101272_bib0070","first-page":"1053","article-title":"Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance","volume":"623","author":"Guo","year":"2023","journal-title":"Nat. 2023 6237989"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558626000011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558626000011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T22:57:19Z","timestamp":1773961039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558626000011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":69,"alternative-id":["S1476558626000011"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2026.101272","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell type composition in bulk prostate cancer tissue is a prognostic biomarker","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2026.101272","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101272"}}